ERWINAZE

Porton Biopharma Limited

Application Filed: 2020-07-29

Trademark Application Details

The mark consists of the word "ERWINAZE" to the left of a multi-lined design.

Mark For: ERWINAZE™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancer, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity. [all]

Status

2021-05-17 UTC

LIVE APPLICATION Under Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	90081574
Mark Literal Elements	ERWINAZE
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED 2020-11-18
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Rebecca Liebowitz
Attorney Name	Rebecca Liebowitz
Attorney Docket Number	31916-526234

Timeline

2020-07-29	Application Filed
2020-08-01	Location: NEW APPLICATION PROCESSING
2020-08-01	Status: Live/Pending
2020-08-01	Transaction Date
2020-11-18	Location: TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
2021-05-11	Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney

Trademark Parties (Applicants & Owners)

Party:	Porton Biopharma Limited
Address	Manor Farm Road Porton, Salisbury Wiltshire UNITED KINGDOM SP40JG
Legal Entity Type	Private Limited Company
Legal Entity State	UNITED KINGDOM

Documents

Application	MULTI	2020-07-29
Drawing	JPEG	2020-07-29
Design Search Code Corr Project	APPLICATION/XML	2020-08-28
Notation to File	XML	2020-11-17
XSearch Search Summary	XML	2020-11-17
Offc Action Outgoing	XML	2020-11-18
Response to Office Action	MULTI	2021-05-10
Amendment and Mail Process Complete	MULTI	2021-05-12

Design Search Codes

26.17.06	Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal
261702	Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s)
261706	Bands, diagonal; Bars, diagonal; Diagonal line(s), band(s) or bar(s); Lines, diagonal

Attorney of Record

REBECCA LIEBOWITZ
VENABLE LLP
P.O. BOX 34385
WASHINGTON, DC 20043

Good, Services, and Codes

IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancer, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
DM0000	The mark consists of the word ERWINAZE to the left of a multi-lined design.

Trademark Filing History

Description	Date	Proceeding Number
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-05-11	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2021-05-10
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-05-10	88889
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2020-11-18	6325
NON-FINAL ACTION WRITTEN	2020-11-18	94649
NON-FINAL ACTION E-MAILED	2020-11-18	6325
ASSIGNED TO EXAMINER	2020-11-17	94649
NOTICE OF DESIGN SEARCH CODE E-MAILED	2020-08-28
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2020-08-27
NEW APPLICATION ENTERED IN TRAM	2020-08-01

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
ERWINAZE 90081574 not registered Live/Pending	Porton Biopharma Limited 2020-07-29
ERWINAZE 85245951 4147569 Live/Registered	PORTON BIOPHARMA LIMITED 2011-02-18
ERWINAZE 85031446 not registered Dead/Abandoned	EUSA Pharma (Europe) Limited 2010-05-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.